Cover Image
市場調查報告書

歐洲的POCT市場:2015∼2019年

POCT Market in Europe 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 351675
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
歐洲的POCT市場:2015∼2019年 POCT Market in Europe 2015-2019
出版日期: 2016年01月27日 內容資訊: 英文 72 Pages
簡介

POCT是在歐洲中成長最快的領域。歐洲的POCT市場,預計2016∼2020年以年複合成長率4.07%擴大。

本報告提供歐洲的POCT市場相關調查,POCT(就地檢驗)概要,市場趨勢與到2020年的預測,市場課題,主要供應商趨勢與主要供應商所面臨的市場機會和威脅等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 POCT檢驗:概要

  • 歐洲的CE認證
  • 歐洲的POCT市場方案

第7章 各用途市場市場區隔

  • 血糖檢驗
  • 傳染病檢查
  • 心臟標記檢驗
  • 凝血檢驗
  • 血氣、電解質檢驗
  • 妊娠檢驗、不孕檢驗
  • 腫瘤標記(癌症篩檢)
  • 膽固醇檢驗
  • 尿液檢查

第8章 推動市場的要素

第9章 促進要素的影響

第10章 市場課題

第11章 促進要素與課題的影響

第12章 市場趨勢

  • 政府對品質改善的配合措施
  • 數位技術的患者中心的醫療
  • 可攜式POCT產品大受歡迎
  • 次世代定序和DNA微陣列

第13章 供應商環境

  • 競爭模式
  • 主要消息
  • Abbott Diagnostics
  • Alere
  • LifeScan
  • Roche Diagnostics
  • Siemens Diagnostics
  • 其他值得注意的供應商

第14章 主要供應商分析

  • Abbott Diagnostics
  • Alere
  • LifeScan
  • Roche Diagnostics
  • Siemens Diagnostics

第15章 附錄

第16章 關於Technavio

圖表

目錄
Product Code: IRTNTR7884

About POCT Market in Europe

POCT is the fastest growing segment of laboratory diagnostics in Europe. It is performed using electronic and non-electronic devices that range from reaction strips to bulky devices. These devices replace a series of laboratory experiments and reduce the turnaround time. POCT diagnostic devices can be categorized into hand-held and near-bedside monitoring devices. The hand-held POCT devices are small, offering mobility while the near-bedside POCT devices are larger and complex. For both the devices, quality control and calibration functionality are checked before performing the tests.

Technavio's analysts forecast the POCT market in Europe to grow at a CAGR of 4.07% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the point-of-care testing (POCT) market in Europe for the period 2015-2019. To calculate the market size, the report considers the revenue generated from sales of POCT diagnostic devices, including instruments and consumables

The market is divided into the following segments based on application:

  • Blood glucose testing
  • Infectious diseases testing
  • Cardiac markers testing
  • Coagulation testing
  • Pregnancy and fertility testing
  • Electrolyte testing
  • Tumor markers testing
  • Urinalysis
  • Cholesterol testing

Technavio's report, POCT Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Alere
  • Bayer Healthcare
  • LifeScan
  • Roche Diagnostics
  • Siemens

Other Prominent Vendors

  • Abaxis
  • A. Menarini Diagnostics
  • Acon Laboratories
  • BD
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostic Systems
  • Clarity Diagnostics
  • DiagCor
  • Helena Laboratories
  • Hologic
  • Life Technologies
  • Landwind Medical
  • Mindray
  • i-Sens
  • Nipro Diagnostics
  • Randox Laboratories
  • Span Diagnostics
  • Snibe Diagnostics
  • Sysmex
  • Trivitron Healthcare
  • URIT

Market driver

  • Patient-driven demand
  • For a full, detailed list, view our report

Market challenge

  • Direct-to-consumer genetic testing
  • For a full, detailed list, view our report

Market trend

  • Government initiatives for quality improvement
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: POCT testing: Overview

  • Conformite Europeene (CE) approval in Europe
  • POCT market scenario in Europe

PART 07: Market segmentation by application

  • Blood glucose testing market in Europe
  • Infectious diseases testing market in Europe
  • Cardiac markers testing market in Europe
  • Coagulation testing market in Europe
  • Blood gas and electrolytes testing market in Europe
  • Pregnancy and fertility testing market in Europe
  • Tumor markers testing market in Europe
  • Cholesterol testing market in Europe
  • Urinalysis market in Europe

PART 08: Market drivers

  • Patient-driven demand
  • Coverage of POCT devices in developed countries
  • Technological innovations
  • Increased healthcare spending

PART 09: Impact of drivers

PART 10: Market challenges

  • Direct-to-consumer (DTC) genetic testing
  • Pricing structure of European healthcare
  • Threat from low-cost products
  • Technology limitations

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Government initiatives for quality improvement
  • Patient-centered healthcare by digital technology
  • Growing popularity of portable POCT products
  • Next-generation sequencing and DNA microarrays

PART 13: Vendor landscape

  • Competitive scenario
  • Abbott Diagnostics
  • Alere
  • LifeScan
  • Roche Diagnostics
  • Siemens Diagnostics
  • Other prominent vendors

PART 14: Key vendor analysis

  • Abbott Diagnostics
  • Alere
  • LifeScan
  • Roche Diagnostics
  • Siemens Healthcare

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: POCT market in Europe 2015-2019 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Difference between diagnostic test and laboratory testing process
  • Exhibit 05: Approval of self-testing IVD
  • Exhibit 06: Market share of POCT market in Europe by country
  • Exhibit 07: Segmentation of POCT market by application
  • Exhibit 08: Blood glucose testing market in Europe 2014-2019 ($ millions)
  • Exhibit 09: Infectious disease testing market in Europe 2014-2019 ($ millions)
  • Exhibit 10: Cardiac markers testing market in Europe 2014-2019 ($ millions)
  • Exhibit 11: Coagulation testing market in Europe 2014-2019 ($ millions)
  • Exhibit 12: Blood gas and electrolytes testing market in Europe 2014-2019 ($ millions)
  • Exhibit 13: Pregnancy and fertility testing market in Europe 2014-2019 ($ millions)
  • Exhibit 14: Tumor marker testing market in Europe 2014-2019 ($ millions)
  • Exhibit 15: Cholesterol testing market in Europe 2014-2019 ($ millions)
  • Exhibit 16: Urinalysis market in Europe 2014-2019 ($ millions)
  • Exhibit 17: POCT market share by products
  • Exhibit 18: Impact of drivers
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: Abbott Diagnostics: Key takeaways
  • Exhibit 21: Alere: Key takeaways
  • Exhibit 22: LifeScan: Key takeaways
  • Exhibit 23: Roche Diagnostics: Key takeaways
  • Exhibit 24: Siemens Diagnostics: Key takeaways
  • Exhibit 25: Abbott Diagnostics: key business offerings
  • Exhibit 26: Alere: Business Segmentation by revenue 2014
  • Exhibit 27: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 28: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
  • Exhibit 29: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 30: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 31: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 32: Siemens Healthcare: Business segmentation
  • Exhibit 33: Siemens Healthcare: Geographical segmentation by revenue 2014
Back to Top